Salvage surgery for recurrent Head and Neck cancer: Is it worthwhile?
09-11, 15:00–15:30 (Europe/Istanbul), Head & Neck Oncology 3

<p>Recurrence after primary treatment of head and neck cancer is associated with significant morbidity and mortality. In terms of treatment options, surgery is considered in many cases to offer the best or only chance of a curative outcome. However, salvage surgery in the Head and Neck is complicated and often associated with poor outcomes and survival. Furthermore, there is a lack of good evidence basis due to heterogeneity in series and variability in management. The aim of this lecture is to review the current status of salvage surgery for recurrent Head and Neck cancer, to review the evidence regarding optimal patient selection and prognostication, and to explore novel alternative approaches for cases of borderline resectability.</p>
<p>To educate participants regarding the evidence basis for salvage surgery, patient selection, functional outcomes, prognostic variables, and new approaches</p>
Session Chair Session Chair
Murat Yener
Speaker Speaker
Patrick Sheahan
Murat Yener
<p>currently working on patients with head and neck cancer in a well known university hospital</p>
This speaker also appears in:
Patrick Sheahan
<p>Graduate of University College Cork, (UCC) Ireland, 1997 (MB BCh, BAO, BMedSc). Awarded MD degree for research and thesis submission by Royal College of Surgeons in Ireland (RCSI), 2006. Completed Higher Surgical Training in Otolaryngology in Royal College of Surgeons in Ireland Training Scheme (2000-2006) and subsequent Fellowship in Head and Neck Surgery in Memorial Sloan Kettering Cancer Center, New York, USA (2007) and Medical University of South Carolina, USA (2008). Appointed as Consultant Otolaryngologist – Head, Neck and Thyroid Surgeon in South Infirmary Victoria University Hospital, Cork, and Cork University Hospital, Cork, Ireland, in 2009, and as Professor of Otolaryngology in University College Cork in 2017. Currently Director of ENTO (Ear, Nose, Throat, and Oral) Research Institute in University College Cork, Regional Lead for Head and Neck Cancer in Ireland South/South-Western Hospital Group, President of Irish Head and Neck Society (IHNS) (2019-2027), and Treasurer-Elect of the Confederation of European Otorhinolaryngology and Head and Neck Surgery (CEORLHNS) (2024-2026). Clinical and research interests in oral cancer, oropharyngeal cancer, laser surgery, thyroid cancer, salivary cancer, and author of 130 peer-reviewed publications.</p>
This speaker also appears in: